Document:

EXHIBIT 10.25

                           PLACEMENT AGENCY AGREEMENT

         THIS PLACEMENT AGENCY AGREEMENT ("Agreement") is made as of this 28th
day of August, 2000, by and between TCPI, Inc., a Florida Corporation
("Company"), The May Davis Group, Inc., a Maryland corporation (the "Agent").

                                   WITNESSETH:

         WHEREAS, the Company proposes to issue and sell, pursuant to the
Securities Purchase Agreement, One Million Five Hundred Thousand Dollars
($1,500,000) of debentures (the "Debentures"), convertible into shares of common
stock, par value $0.001 per share, of the Company (the "Securities"), resulting
in gross proceeds to the Company of $1,500,000 (the "Offering") in one or more
series of transactions outside of the U.S. to purchasers who are not citizens or
residents of the U.S., and not involving a public offering and without
registration under the Securities Act of 1933, as amended (the "Act"), pursuant
to one or more of the exemptions from the registration requirements of the Act
provided by Section 4(2), Rule 506 of Regulation D promulgated under the Act
("Regulation D"), or Regulation S promulgated under the Act ("Regulation D") as
described below; and

         WHEREAS, the Agent is willing to assist the Company in placing the
Securities on a "best efforts basis" basis and the Company desires to secure the
services of the Agent on the terms and conditions hereinafter set forth;

         NOW, THEREFORE, in consideration of the premises and the mutual
promises, conditions and covenants herein contained, the parties hereto do
hereby agree as follows:

         1.       Engagement of Agent. The Company hereby appoints the Agent as
its placement agent for the Offering pursuant to the Securities Purchase
Agreement, on a "best efforts" resulting in gross proceeds to the Company of
$1,500,000 (the "Maximum Amount"). The Agent, on the basis of the
representations and warranties herein contained, but subject to the terms and
conditions herein set forth, accepts such appointment and agrees to use its
reasonable best efforts to find purchasers for the Securities. This appointment
shall be irrevocable for the period commencing as of the date hereof and ending
as further described in Section 8, which period may be extended by the consent
of the Company and the Agent (the "Offering Period").

         2.       Representations and Warranties of the Company. In order to
induce the Agent to enter into this Agreement, the Company hereby represents and
warrants to and agrees with the Agent as follows:

                  2.1. Organization and Qualification. The Company and its
         subsidiaries are corporations duly organized and validly existing in
         good standing under the laws of the jurisdiction in which they are
         incorporated, and have the requisite corporate power to own their
         properties and to carry on their business as now being conducted. Each
         of the Company and its subsidiaries is duly qualified as a foreign
         corporation to do business and is in good standing in every
         jurisdiction in which the nature of the business conducted by it makes
         such qualification necessary, except to the extent that the failure to
         be so qualified or be in good standing would not have a material
         adverse effect on the Company and its subsidiaries taken as a whole.

<PAGE>

                  2.2. Authorization, Enforcement, Compliance with Other
         Instruments. The Company has the requisite corporate power and
         authority to enter into and perform this Agreement. This Agreement has
         been duly authorized by the Company's Board of Directors and no further
         consent or authorization is required by the Company, its Board of
         Directors or its stockholders. This Agreement, constitutes the valid
         and binding obligations of the Company enforceable against the Company
         in accordance with its terms, except as such enforceability may be
         limited by general principles of equity or applicable bankruptcy,
         insolvency, reorganization, moratorium, liquidation or similar laws
         relating to, or affecting generally, the enforcement of creditors'
         rights and remedies.

                  2.3. No Conflicts. Except as disclosed in Schedule 2.3, the
         execution, delivery and performance of this Agreement by the Company
         and the consummation by the Company of the transactions contemplated
         hereby will not (i) result in a violation of the Certificate of
         Incorporation, any Certificate of Designations, Preferences, and Rights
         of any outstanding series of preferred stock of the Company or By-laws
         or (ii) conflict with or constitute a default (or an event which with
         notice or lapse of time or both would become a default) under, or give
         to others any rights of termination, amendment, acceleration or
         cancellation of, any agreement, indenture or instrument to which the
         Company or any of its subsidiaries is a party, or, to the best of the
         Company's knowledge, result in a violation of any law, rule,
         regulation, order, judgment or decree (including federal and state
         securities laws and regulations and the rules and regulations of The
         Nasdaq Stock Market, Inc.'s National Market or OTC Bulletin Board on
         which the common stock, $0. 001 par value per share, of the Company
         ("Common Stock") is quoted) applicable to the Company or any of its
         subsidiaries or by which any property or asset of the Company or any of
         its subsidiaries is bound or affected. Except as disclosed in Schedule
         2.3, neither the Company nor its subsidiaries is in violation of any
         term of or in default under its Certificate of Incorporation or By-laws
         or their organizational charter or by-laws, respectively, or any
         material contract, agreement, mortgage, indebtedness, indenture,
         instrument, judgment, decree or order or any statute, rule or
         regulation applicable to the Company or its subsidiaries. To the best
         knowledge of the Company, the business of the Company and its
         subsidiaries is not being conducted, and the Company shall use its best
         efforts to assure that it shall not in all material respects be
         conducted in violation of any law, ordinance, regulation of any
         governmental entity. Except as specifically contemplated by this
         Agreement and as required under the Act and any applicable state
         securities laws, the Company is not required to obtain any consent,
         authorization or order of, or make any filing or registration with, any
         court or governmental agency in order for it to execute, deliver or
         perform any of its obligations under or contemplated by this Agreement
         in accordance with the terms hereof or thereof. Except as disclosed in
         Schedule 2.3, all consents, authorizations, orders, filings and
         registrations which the Company is required to obtain pursuant to the
         preceding sentence have been obtained or effected on or prior to the
         date hereof. The Company and its subsidiaries are unaware of any facts
         or circumstances, which might give rise to any of the foregoing.

                                        2

<PAGE>

                  2.4. SEC Documents: Financial Statements. The Company has
         filed all reports, schedules, forms, statements and other documents
         required to be filed by it with the Securities and Exchange Commission
         ("SEC") pursuant to the reporting requirements of the Securities
         Exchange Act of 1934, as amended (the "1934 Act") (all of the foregoing
         filed prior to the date hereof and all exhibits included therein and
         financial statements and schedules thereto and documents incorporated
         by reference therein, being hereinafter referred to as the "SEC
         Documents"). The Company has delivered to the Agent or its
         representative, or made available through the SEC's electronic web site
         located at http://www.sec.gov, true and complete copies of the SEC
         Documents. As of their respective dates, the financial statements of
         the Company disclosed in the SEC Documents (the "Financial Statements")
         complied as to form in all material respects with applicable accounting
         requirements and the published rules and regulations of the SEC with
         respect thereto. Such financial statements have been prepared in
         accordance with generally accepted accounting principles, consistently
         applied, during the periods involved (except (i) as may be otherwise
         indicated in such financial statements or the notes thereto, or (ii) in
         the case of un-audited interim statements, to the extent they may
         exclude footnotes or may be condensed or summary statements) and fairly
         present in all material respects the financial position of the Company
         as of the dates thereof and the results of its operations and cash
         flows for the periods then ended (subject, in the case of un-audited
         statements, to normal year-end audit adjustments). No other information
         provided by the Company in writing to the Buyer which is not included
         in the SEC Documents, including, without limitation, information
         referred to in Section 2.6 of this Agreement, contains any untrue
         statement of a material fact or omits to state any material fact
         necessary in order to make the statements therein, in the light of the
         circumstance under which they are or were made, not misleading.

                  2.5. Absence of Litigation. Except as disclosed in the SEC
         Documents, there is no action, suit, proceeding, inquiry or
         investigation before or by any court, public board, government agency,
         self-regulatory organization or body pending or, to the knowledge of
         the Company or any of its subsidiaries, threatened against or affecting
         the Company, the Common Stock or any of the Company's subsidiaries,
         wherein an unfavorable decision, ruling or finding would (i) have a
         material adverse effect on the transactions contemplated hereby (ii)
         adversely affect the validity or enforceability of, or the authority or
         ability of the Company to perform its obligations under, this Agreement
         or any of the documents contemplated herein or (iii) except as
         expressly disclosed in the SEC Documents, have a material adverse
         effect on the business, operations, properties, financial condition or
         results of operation of the Company and its subsidiaries taken as a
         whole.

                  2.6. No Materially Adverse Contracts, Etc. Except as set forth
         in the SEC Documents, neither the Company nor any of its subsidiaries
         is subject to any charter, corporate or other legal restriction, or any
         judgment, decree, order, rule or regulation which in the judgment of
         the Company's officers has or is expected in the future to have a

                                       3

<PAGE>

         material adverse effect on the business, properties, operations,
         financial condition, results of operations or prospects of the Company
         or its subsidiaries. Neither the Company nor any of its subsidiaries is
         a party to any contract or agreement which in the judgment of the
         Company's officers has or is expected to have a material adverse effect
         on the business, properties, operations, financial condition, results
         of operations or prospects of the Company or its subsidiaries.

         3.       Issue, Sale and Delivery of the Securities.

                  3.1. Deliveries of Securities. Certificates in such form,
         subject to applicable transfer restrictions as described in the
         Securities Purchase Agreement proposed to be entered into between the
         Company and Investors ("Purchase Agreement"), and and copies of
         warrants representing the Agent's and Butler Gonzalez's warrant
         compensation described in Section 3.4(b) below ("Warrants"), shall be
         delivered by the Company to counsel to the Agent, with copies made
         available to the Agent for checking at least one (1) full business day
         prior to the Closing Date, it being understood that the directions from
         the Agent to the Company shall be given at least two (2) full business
         days prior to the Closing Date. The certificates for the Securities and
         the Warrants shall be delivered at the Closing (as hereinafter
         defined).

            3.2. Escrow of Funds. Pending Closing purchasers shall place all
         funds for purchase of Securities, in an escrow account with an escrow
         agent to be designated by the Company and the Placement Agent ("Escrow
         Agent") and as set up by the Company in accordance with the terms of an
         escrow agreement between the Company, the Agent and the Escrow Agent.
         The Company shall have the right to approve or object to the
         subscriptions of any purchaser. At such time as purchasers purchasing
         the Debentures have delivered to the Agent a signed Purchase Agreement,
         and provided those purchasers have been approved by the Company and all
         other Closing conditions have been met, Escrow Agent shall release the
         subscription funds to the Company and the Company shall release the
         certificates representing the Securities to the subscribers (the
         "Closing"). In the event the Closing is not held on or before August
         28, 2000, (the "Escrow Period") all subscription proceeds shall be
         immediately returned to purchasers without deduction or charge by the
         Escrow Agent, unless the Escrow Period is extended by the parties
         mutually.

            3.3. Closing Date. The Closing shall take place at the offices of
         Butler Gonzalez LLP, 1000 Stuyvesant Avenue, Suite 6, Union, New Jersey
         07083 at such time and date ("Closing Date") as will be fixed either
         orally or in writing by notice to be given by the Agent to the Company
         after consultation with the Company, such Closing Date to be not less
         than one (1) full business day after the date on which such notice
         shall have been given. The Closing Date may be changed by mutual
         written agreement of the Agent and the Company.

                                       4

<PAGE>

            3.4. Agent's Compensation. The Company shall pay the Agent:

                 (a) A commission of Ten Percent (10%) of the gross subscription
            proceeds received by the Company, pursuant to the sale of the
            Debentures, pursuant to the Securities Purchase Agreement at the
            Closing to be paid in cash or Common Stock of the Company as
            determined by the Agent (the "Gross Proceeds"); and

                 (b) In addition to the fees and reimbursement of costs set
            forth in Sections 3.4(a) and 3.5 of this Agreement, upon closing
            with respect to the sale of the Debentures at the Closing, the
            Company shall issue to the Agent, and/or its assignees warrants to
            purchase up to 2,000,000 shares of the Company's Common Stock. Such
            warrants shall be exercisable at a price of $1.50. The Warrants
            shall have cashless exercise provisions which shall expire
            immediately upon the declaration of effectiveness of a registration
            statement applicable to the securities. The term of the Warrants
            shall be five years. The Company shall have the right to force
            conversion of the Warrants if the common stock of the Company closes
            as a bid price of $3.00 or higher for ten (10) consecutive trading
            days. The shares of Common Stock issuable upon exercise of the
            Warrants shall have registration rights as described in the
            Registration Rights Agreement, it being understood that, if the SEC
            requires removal of the Warrants from any registration statement in
            which the Warrants have a right by contract to be included, the
            removal of the Warrants shall not constitute a breach of contract by
            the Company, and the Company will use best efforts to include the
            Warrants (or underlying shares) in a registration statement in a
            manner acceptable to the SEC. Except as set forth in the immediately
            preceding sentence, it is specifically understood by the Company
            that the Company must register the Shares underlying the Warrants
            for the Agent in the same registration statement described in the
            Registration Rights Agreements between the Company and purchasers
            and contemplated by the Purchase Agreement. The Warrants shall be
            delivered by the Company to the Agent simultaneous with and
            contingent upon a Closing with respect to the Maximum Amount.

            3.5. Payment of Fees. The Escrow Agent shall be instructed at
         closing to:

                 (a) Pay the Placement Agent's fees and all of the reasonable
            legal, administrative, and escrow fees, associated with the sale of
            the Debentures, of The May Davis Group, Inc.'s counsel, Butler
            Gonzalez, LLP, in the amount of Seventeen Thousand Five Hundred
            Dollars ($17,500), directly to the Agent's counsel from the proceeds
            of the sale of the Debentures simultaneous with the transfer of
            proceeds to the Company

                 (b) In addition to the fees and reimbursement of costs set
            forth in Sections 3.5 of this Agreement, upon closing with respect
            to the sale of the Debentures at the Closing, the Company shall
            issue to the Butler Gonzalez, LLP., and/or its assignees

                                       5

<PAGE>

            warrants to purchase ten thousand (10,000) shares of the Company's
            Common Stock. Such warrants shall be exercisable at a price of
            $1.50. The Warrants shall have cashless exercise provisions which
            shall expire immediately upon the declaration of effectiveness of a
            registration statement applicable to the securities. The term of the
            Warrants shall be five years. The Company shall have the right to
            force conversion of the Warrants if the common stock of the Company
            closes as a bid price of $3.00 or higher for ten (10) consecutive
            trading days. The shares of Common Stock issuable upon exercise of
            the Warrants shall have registration rights as described in the
            Registration Rights Agreement, it being understood that, if the SEC
            requires removal of the Warrants from any registration statement in
            which the Warrants have a right by contract to be included, the
            removal of the Warrants shall not constitute a breach of contract by
            the Company, and the Company will use best efforts to include the
            Warrants (or underlying shares) in a registration statement in a
            manner acceptable to the SEC. Except as set forth in the immediately
            preceding sentence, it is specifically understood by the Company
            that the Company must register the Shares underlying the Warrants
            for the Agent in the same registration statement described in the
            Registration Rights Agreements between the Company and purchasers
            and contemplated by the Purchase Agreement. The Warrants shall be
            delivered by the Company to the Butler Gonzalez, LLP simultaneous
            with and contingent upon a Closing with respect to the Maximum
            Amount.

         4.       Offering of the Securities on Behalf of the Company.

                  4.1. In offering the Securities for sale, the Agent shall
         offer them solely as an agent for the Company, and such offer shall be
         made upon the terms and subject to the conditions set forth in the
         Securities Purchase Agreement. The Agent shall commence making such
         offer as an agent for the Company as soon as possible following
         delivery of the Purchase Agreement and shall conduct such offering in
         accordance will all applicable laws.

                  4.2. The Agent will not make offers to sell the Securities to,
         or solicit offers to subscribe for any Securities from, persons or
         entities that are not "accredited investors" as defined in Regulation
         D.

         5.       Non-Circumvention.  The Company hereby agrees as follows:

                  5.1. The Company agrees to maintain the confidentiality of the
         Agent's clients, except as required by applicable law. Such clients
         shall be those entities, which invest or have been offered an
         opportunity to invest by the Agent in the Offering (the "Clients"). For
         a period of two years from the Closing, the Company will not solicit or
         enter into any financing transaction with the Clients without the
         written consent of Agent and payment to Agent compensation no less than
         the compensation to be paid to Agent hereunder for raising a like
         amount.

                                       6

<PAGE>

                  5.2. In the event that Company breaches Section 5.1 of this
         Agreement, Agent shall be entitled to receive compensation in the same
         proportion to the financing done without Agent's participation as the
         compensation to Agent under this Agreement bears to the financing
         raised in this Offering.

         6.       Covenants of the Company. The Company covenants and agrees
     with the Agent that:

                  6.1. After the date hereof, the Company will not at any time,
         prepare and distribute any amendment or supplement to the Securities
         Purchase Agreement, of which amendment the Agent shall not previously
         have been advised and the Agent and its counsel furnished with a copy
         within a reasonable time period prior to the proposed adoption thereof,
         or to which the Agent shall have reasonable objected in writing on the
         ground that it is not in compliance with the Act or the Rules and
         Regulations under the Act (if applicable).

                  6.2. The Company will pay, whether or not the transactions
         contemplated hereunder are consummated or this Agreement is prevented
         from becoming effective or is terminated, all costs and expenses
         incident to the performance of its obligations under this Agreement,
         including all expenses incident to the authorization of the Securities
         and their issue and delivery to the purchasers, any original issue
         taxes in connection therewith, all transfer taxes, if any, incident to
         the initial sale of the Securities, the fees and expenses of the
         Company's counsel and Agent's counsel as set forth in Section 3.5
         (except as provided below) and accountants, the cost of reproduction
         and furnishing to the Agent copies of the Purchase Agreement as herein
         provided.

                  6.3 Prior to the Closing Date, and during the normal business
         hours, the Company will cooperate with the Agent in such investigation
         as it may make or cause to be made of all of the properties, business
         and operations of the Company in connection with the Offering of the
         Securities. The Company will make available to it in connection
         therewith such information in its possession as the Agent may
         reasonably request and will make available to the Agent such persons as
         the Agent shall deem reasonably necessary and appropriate in order to
         verify or substantiate any such information so supplied.

                  6.4 The Company shall be responsible for making any and all
         filings required by the Blue Sky authorities and filings required by
         the laws of the jurisdictions in which the purchasers who are accepted
         for purchase of Securities are located, if any. Agent shall assist
         Company in this respect, but such filings shall be the responsibility
         of Company.

                  6.5 Corporation Condition. The Company's condition is as
         described in the Purchase Agreement and the SEC Documents referred to
         therein, except for changes in the ordinary course of business and
         normal year-end adjustments that are not individually or in the
         aggregate materially adverse to the Company.

                                       7

<PAGE>

                  6.6 No Material Adverse Change. Except as may be reflected in
         or contemplated by the Purchase Agreement prior to the Closing, there
         shall not have been any material adverse change in the condition,
         financial, or otherwise, or in the results of operations of the Company
         or in its business taken as a whole.

         7.       Indemnification.

                  7.1. The Company agrees to indemnify and hold harmless the
         Agent, each person who controls the Agent within the meaning of Section
         15 of the Act and the Agent's employees, accountants, attorneys and
         agents (the "Agent's Indemnitees") against any and all losses, claims,
         damages or liabilities, joint or several, to which they or any of them
         may become subject under the Act or any other statute or at common law
         for any legal or other expenses (including the costs of any
         investigation and preparation) incurred by them in connection with any
         litigation, whether or not resulting in any liability, but only insofar
         as such losses, claims, damages, liabilities and litigation arise out
         of or are based upon any untrue statement of material fact contained in
         the Securities Purchase Agreement or any amendment thereto or any
         application or other document filed in any state or jurisdiction in
         order to qualify the Securities under the Blue Sky or securities laws
         thereof, or the omission to state therein a material fact required to
         be stated therein or necessary to make the statements therein, under
         the circumstances under which they were made, not misleading, all as of
         the date of the Purchase Agreement or of such amendment as the case may
         be; provided, however, that the indemnity agreement contained in this
         Section 7.1 shall not apply to amounts paid in settlement of any such
         litigation, if such settlements are made without the consent of the
         Company, nor shall it apply to the Agent's Indemnitees in respect to
         any such losses, claims, damages or liabilities arising out of or based
         upon any such untrue statement or any such omission, if such statement
         or omission was made solely in reliance upon information furnished in
         writing to the Company by the Agent specifically for use in connection
         with the preparation of the Purchase Agreement or any such amendment
         thereto or any application or other document filed in any state or
         jurisdiction in order to qualify the Securities under the Blue Sky or
         securities law thereof. This indemnity agreement is in addition to any
         other liability, which the Company may otherwise have to the Agent's
         Indemnitees. The Agent's Indemnitees agree, within ten (10) days after
         the receipt by them of written notice of the commencement of any action
         against them in respect to which indemnity may be sought from the
         Company under this Section 7.1, to notify the Company in writing of the
         commencement of such action; provided, however, that the failure of the
         Agent's Indemnitees to notify the Company of any such action shall not
         relieve the Company from any liability which it may have to the Agent's
         Indemnitees on account of the indemnity agreement contained in this
         Section 7.1, and further shall not relieve the Company from any other
         liability which it may have to the Agent's Indemnitees, and if the
         Agent's Indemnitees shall notify the Company of the commencement
         thereof, the Company shall be entitled to participate in (and, to the
         extent that the Company shall wish, to direct) the defense thereof at
         its own expense, but such defense shall be conducted by counsel of
         recognized standing and reasonably satisfactory to the Agent's
         Indemnitees, defendant or defendants, in such litigation. The Company
         agrees to notify the Agent's Indemnitees promptly of the commencement
         of any litigation or proceedings

                                       8

<PAGE>

         against the Company or any of the Company's officers or directors of
         which the Company may be advised in connection with the issue and sale
         of any of the Securities and to furnish to the Agent's Indemnitees, at
         their request, to provide copies of all pleadings therein and to permit
         the Company's Indemnitees to be observers therein and apprise the
         Agent's Indemnitees of all developments therein, all at the Company's
         expense.

                  7.2. The Agent agrees, in the same manner and to the same
         extent as set forth in Section 7.1 above, to indemnify and hold
         harmless the Company, and the Company's employees, accountants,
         attorneys and agents (the "Company's Indemnitees") with respect to (i)
         any statement in or omission from the Purchase Agreement or any
         amendment thereto or any application or other document filed in any
         state or jurisdiction in order to qualify the Securities under the Blue
         Sky or securities laws thereof, or any information furnished pursuant
         to Section 3.4 hereof, if such statement or omission was made solely in
         reliance upon information furnished in writing to the Company by the
         Agent on its behalf specifically for use in connection with the
         preparation thereof or supplement thereto, or (ii) any untrue statement
         of a material fact made by the Agent or its agents not based on
         statements in the Purchase Agreement or authorized in writing by the
         Company, or with respect to any misleading statement made by the Agent
         or its agents resulting from the omission of material facts which
         misleading statement is not based upon the Purchase Agreement, or
         information furnished in writing by the Company or, (iii) any breach of
         any representation, warranty or covenant made by the Agent in this
         Agreement. The Agent's liability hereunder shall be limited to the
         amount received by it for acting as Agent in connection with the
         Offering. The Agent shall not be liable for amounts paid in settlement
         of any such litigation if such settlement was effected without its
         consent. In case of the commencement of any action in respect of which
         indemnity may be sought from the Agent, the Company's Indemnitees shall
         have the same obligation to give notice as set forth in Section 7.1
         above, subject to the same loss of indemnity in the event such notice
         is not given, and the Agent shall have the same right to participate in
         (and, to the extent that it shall wish, to direct) the defense of such
         action at its own expense, but such defense shall be conducted by
         counsel of recognized standing reasonably satisfactory to the Company.
         The Agent agrees to notify the Company's Indemnitees and, at their
         request, to provide copies of ail pleadings therein and to permit the
         Company's Indemnitees to be observers therein and apprise them of all
         the developments therein, all at the Agent's expense.

         8.       Effectiveness  of Agreement.  This Agreement shall become
effective upon the date of the execution hereof and shall remain in full force
and effect until the Closing or Closings as the case may be.

         9.       Conditions of the Agent's Obligations. The Agent's obligations
to act as agent of the Company hereunder and to find purchasers for the
Securities shall be subject to the accuracy in all material respects, as of the
Closing Date, of the representations and warranties on the part of the Company
herein contained, to the fulfillment of or compliance by the Company with all
covenants and conditions hereof, and to the following additional conditions:

                                       9

<PAGE>

                  9.l. Counsel to the Agent shall not have objected in good
         faith in writing or shall not have failed to give his consent to the
         Securities Purchase Agreement (which objection or failure to give
         consent shall not have been done unreasonably).

                  9.2. The Agent shall not have disclosed to the Company that
         the Purchase Agreement, or any amendment thereof, contains an untrue
         statement of fact, which, in the opinion of counsel to the Agent, is
         material, or omits to state a fact, which, in the opinion of such
         counsel, is material and is required to be stated therein, or is
         necessary to make the statements therein, under the circumstances in
         which they were made, not misleading.

                  9.3. Between the date hereof and the Closing Date, the Company
         shall not have sustained any loss on account of fire, explosion, flood,
         accident, calamity or any other cause of such character as would
         materially adversely affect its business or property considered as an
         entire entity, whether or not such loss is covered by insurance.

                  9.4. Between the date hereof and the Closing Date, there shall
         be no litigation instituted or threatened against the Company, and
         there shall be no proceeding instituted or threatened against the
         Company before or by any federal or state commission, regulatory body
         or administrative agency or other governmental body, domestic or
         foreign, wherein an unfavorable ruling, decision or finding would
         materially adversely affect the business, franchises, license, permits,
         operations or financial condition or income of the Company.

                  9.5. Except as contemplated herein or as set forth in the
         Securities Purchase Agreement, during the period subsequent to the most
         recent financial statements referred to in the Securities Purchase
         Agreement, if any, and prior to the Closing Date, the Company (i) shall
         have conducted its business in the usual and ordinary manner as the
         same is being conducted as of the date hereof and (ii) except in the
         ordinary course of business, the Company shall not have incurred any
         liabilities or obligations (direct or contingent) or disposed of any
         assets, or entered into any material transaction or suffered or
         experienced any substantially adverse change in its condition,
         financial or otherwise. At the Closing Date, the equity account of the
         Company shall be substantially the same as reflected in the most recent
         balance sheet referred to in the Securities Purchase Agreement without
         considering the proceeds from the sale of the Securities or any filings
         the Company has made under the Act.

                  9.6. The authorization of the Securities by the Company and
         all proceedings and other legal matters incident thereto and to this
         Agreement shall be reasonably satisfactory in all respects to counsel
         to the Agent, who shall have furnished the Agent on the Closing Date
         with such favorable opinion with respect to the sufficiency of all
         corporate proceedings and other legal matters relating to this
         Agreement as the Agent may reasonably require, and the Company shall
         have furnished such counsel such documents as he may have requested to
         enable him to pass upon the matters referred to in this subparagraph.

                                       10

<PAGE>

                  9.7. The Company shall have furnished to the Agent the
         opinion, dated the Closing Date, addressed to the Agent, from counsel
         to the Company, as required by the Securities Purchase Agreement.

                  9.8. The Company shall have furnished to the Agent a
         certificate of the Chief Executive Officer and the Chief Financial
         Officer of the Company, dated as of the Closing Date, to the effect
         that:

                           (i) the representations and warranties of the Company
                  in this Agreement are true and correct in all material
                  respects at and as of the Closing Date (other than
                  representations and warranties which by their terms are
                  specifically limited to a date other than the Closing Date),
                  and the Company has complied with all the agreements and has
                  satisfied all the conditions on its part to be performed or
                  satisfied at or prior to the Closing Date; and

                           (ii) the respective signers have each carefully
                  examined the Purchase Agreement, and any amendments thereto,
                  and, to the best of their knowledge, all statements contained
                  in the Purchase Agreement are true and correct, and neither
                  the Purchase Agreement, nor any amendment thereto, includes
                  any untrue statement of a material fact or omits to state a
                  material fact required to be stated therein or necessary to
                  make the statements therein, under the circumstances in which
                  they were made, not misleading; except as set forth in the
                  Purchase Agreement, since the respective dates as of which or
                  the periods for which the information is given in the Purchase
                  Agreement and prior to the date of such certificate, (a) there
                  has not been any substantially adverse change, financial and
                  otherwise, in the affairs of condition in the Company, and (b)
                  the Company has not incurred any material liabilities, direct
                  or contingent, or entered into any material transactions,
                  otherwise than in the ordinary course of business.

         10.      Termination.

                  10.1. This Agreement may be terminated by the Agent by written
         notice to the Company in the event that the Company shall have failed
         or been unable to comply with any of the terms, conditions or
         provisions of this Agreement on the part of the Company to be
         performed, complied with or fulfilled within the respective times, if
         any, herein provided for, unless compliance therewith or performance or
         satisfaction thereof shall have been expressly waived by the Agent in
         writing.

                  10.2. This Agreement may be terminated by the Company by
         written notice to the Agent in the event that the Agent shall have
         failed or been unable to comply with any of the terms, conditions or
         provisions of this Agreement on the part of the Agent to be performed,
         complied with or fulfilled within the respective times, if any, herein
         provided for, unless compliance therewith or performance or
         satisfaction thereof shall have been expressly waived by the Company in
         writing.

                                       11

<PAGE>

                  10.3. Any termination of this Agreement pursuant to this
         Section shall be without liability of any character (including, but not
         limited to, loss of anticipated profits or consequential damages) on
         the part of any party thereto, except that the Company shall remain
         obligated to pay the costs and expenses provided to be paid by it
         specified in Sections 3.5; and the Company and the Agent shall be
         obligated to pay, respectively, all losses, claims, damages or
         liabilities, joint or several, under Section 7.1 in the case of the
         Company and Section 7.2 in the case of the Agent.

         11.      Agent's Representations, Warranties, and Covenants. The Agent
represents and warrants to and agrees with the Company that:

                  11.1. Agent is a corporation duly incorporated and existing
         under the laws of the State of Maryland . Agent is registered with the
         Securities Exchange Commission and is a member in good standing of the
         NASD.

                  11.2. Agent understands and acknowledges that the Securities
         are not being registered under the Act, and that the Offering is to be
         conducted pursuant to Regulation D, Section 4(2) of the Act, or
         Regulation S, and that the Company is not making the disclosures
         required for offerings to purchasers other than accredited investors.
         Accordingly, in conducting its activities under this Agreement, Agent
         shall offer Securities only to "accredited investors," as defined in
         Regulation D.

                  11.4. All corporate actions by Agent required for the
         execution, delivery and performance of this Agreement have been taken.
         The execution and delivery of this Agreement by the Agent, the
         observance and performance thereof, and the consummation of the
         transactions contemplated herein or in the Purchase Agreement do not
         and will not constitute a material breach of, or a material default
         under, any instrument or agreement by which the Agent is bound, and
         does not and will not, to the best of the Agent's knowledge, contravene
         any existing law, decree or order applicable to it. This Agreement
         constitutes a valid and binding agreement of Agent, enforceable in
         accordance with its terms.

                  11.5. Agent's representations and warranties under this
         Section shall be true and correct as of the Closing, and shall survive
         the Closing for a period of six months.

         12.      Notices. Except as otherwise expressly provided in this
Agreement:

                  12.1. Whenever notice is required by the provisions of this
         Agreement to be given to the Company, such notice shall be in writing,
         addressed to the Company, at:

                     If to Company:   TCPI, Inc.
                                      3341 S.W. 15th Street
                                      Pompano Beach, FL
                                      Attention: Elliot Block, Ph.D.
                                      Chief Executive Officer

                                12

<PAGE>

                     with a copy to:  Jay E. Eckhaus, Esq.
                                      3341 S.W. 15th Street
                                      Pompano Beach, FL

              and

                                      Teddy D. Klinghoffer, Esq.
                                      Akerman, Senterfitt & Eidson, P.A.
                                      Suntrust International Center, 26th Floor
                                      One S.E. 3rd Avenue
                                      Miami, FL  33131-1714

                  12.2. Whenever notice is required by the provisions of this
         Agreement to be given to the Agent, such notice shall be given in
         writing, addressed to the Agent, at:

                  If to the Agent:    The May Davis Group Inc.
                                      One World Trade Center 87th Floor
                                      New York, NY 10078
                                      Attention: Mr. Michael Jacobs

                     with copy to:    Butler Gonzalez LLP
                                      1000 Stuyvesant Avenue Suite #6
                                      Union, NJ  07083
                                      Attention: David Gonzalez, Esq.

                  12.3. Any notice instructing the Escrow Agent to distribute
         monies or Securities held in Escrow must be signed by authorized agents
         of both the Company and the Agent in order to be valid.

         13.      Miscellaneous.

                  13.1. Benefit. This Agreement is made solely for the benefit
         of the Agent and the Company, their respective officers and directors
         and any controlling person referred to in Section 15 of the Act and
         their respective successors and assigns, and no other person may
         acquire or have any right under or by virtue of this Agreement,
         including, without limitation, the holders of any Securities. The term
         "successor" or the term "successors and assigns" as used in this
         Agreement shall not include any purchasers, as such, of any of the
         Securities.

                  13.2. Survival. The respective indemnities, agreements,
         representations, warranties, covenants and other statements of the
         Company and the Agent, or

                                       13

<PAGE>

         the officers, directors or controlling persons of the Company and the
         Agent as set forth in or made pursuant to this Agreement and the
         indemnity agreements of the Company and the Agent contained in Section
         7 hereof shall survive and remain in full force and effect, regardless
         of (i) any investigation made by or on behalf of the Company or the
         Agent or any such officer, director or controlling person of the
         Company or of the Agent; (ii) delivery of or payment for the
         Securities; or (iii) the Closing Date, and any successor of the Company
         or the Agent or any controlling person, officer or director thereof, as
         the case may be, shall be entitled to the benefits hereof.

                  13.3. Governing Law. The validity, interpretation, and
         construction of this Agreement will be governed by the laws of the
         State of New York. The parties further agree that any action between
         them shall be heard in New York County, New York, and expressly consent
         to the jurisdiction and venue of the Supreme Court of New York County,
         New York, and the United States District Court for the Southern
         District of New York for the adjudication of any civil action asserted
         pursuant to this Paragraph.

                  13.4. Counterparts. This Agreement may be executed in any
         number of counterparts, each of which may be deemed an original and all
         of which together will constitute one and the same instrument.

                  13.5. Confidential Information. All confidential financial or
         business information (except publicly available or freely usable
         material otherwise obtained from another source) respecting either
         party will be used solely by the other party in connection with the
         within transactions, be revealed only to employees or contractors of
         such other party who are necessary to the conduct of such transactions,
         and be otherwise held in strict confidence.

                  13.6. Public Announcements. Prior to the Closing Date, neither
         party hereto will issue any public announcement concerning the within
         transactions without the approval of the other party, except as may be
         required by applicable securities or other laws.

                  13.7. Finders. The parties acknowledge that no person has
         acted as a finder in connection with the transactions contemplated
         herein and each will agree to indemnify the other with respect to any
         other claim for a finder's fee in connection with the offering.

                  13.8. Financial Advisers. The parties acknowledge that the
         Company has or may retain financial and other advisers in connection
         with this transaction (the "Advisers"), and the Company agrees to
         indemnify and hold the Placement Agent harmless for any fees and
         expenses of the Advisers.

                  13.9. Recitals. The recitals to this Agreement are a material
         part hereof, and each recital is incorporated into this Agreement by
         reference and made a part of this Agreement.

                                       14

<PAGE>

                  13.10. Entire Agreement. This Agreement constitutes the entire
         agreement between the parties with regard to the subject matter hereof
         and supersedes all prior agreements or understandings between the
         parties.

                  13.11 Assignment. This Agreement may not be assigned without
         the Company's prior written approval.

         IN WITNESS WHEREOF, the parties hereto have duly caused this Agreement
to be executed as of the day and year first above written.

ATTEST:                                     COMPANY:
                                            TCPI, INC.

/s/Jay E. Eckhaus                           By: /s/ Walter V. Usinowicz,Jr.
------------------                               --------------------------
Name: Jay E. Eckhaus                        Name:  Walter V. Usinowicz
Title: Secretary                            Title: Chief Financial Officer

                                            THE MAY DAVIS GROUP INC.

                                            By: /s/ Michael Jacobs
                                                -------------------------------
                                            Name:  Michael Jacobs
                                            Title: Managing Director

                                       15EXHIBIT 10.26

         LINE OF CREDIT AGREEMENT dated as of 5th day of September 2000, (the
"Agreement") between the entities listed on Exhibit A attached hereto, GMF
Holdings (collectively referred to as the "Investor"), and TCPI, Inc., a
corporation organized and existing under the laws of the State of Florida (the
"Company").

         WHEREAS, the parties desire that, upon the terms and subject to the
conditions contained herein, the Company shall issue and sell to the Investor,
from time to time as provided herein, and the Investor shall purchase up to Ten
Million dollars ($10,000,000) of Debentures for a total purchase price of Ten
Million dollars ($10,000,000); and

         WHEREAS, such investments will be made in reliance upon the provisions
of Section 4(2) ("Section 4(2)") and the Regulation D ("Regulation D") of the
Securities Act of 1933, as amended, and the regulations promulgated there under
(the "Securities Ac"), and or upon such other exemption from the registration
requirements of the Securities Act as may be available with respect to any or
all of the investments in the Debentures to be made hereunder; and

         NOW, THEREFORE, the parties hereto agree as follows:

                                    ARTICLE I

                               Certain Definitions

         Section 1.1 "Advance" shall mean each occasion the Company elects to
exercise its right to tender an Advance Notice requiring the Investor to advance
funds to the Company, subject to the terms of this Agreement.

         Section 1.2 "Advance Date" shall mean the date on which funds are
disbursed to the Company No Advance Date shall be less than thirty five (35)
Calander Days after an Advance Notice Date

         Section 1.3 "Advance Notice" shall mean a written notice to the
Investor setting forth the Advance Amount that the Company requests from the
Investor and Compliance Certification from the Company as attached hereto as
Exhibit B.

         Section 1.4 "Bid Price" shall mean, on any date, the closing bid price
(as reported by Bloomberg L.P.) of the Common Stock on the Principal Market or
if the Common Stock is not traded on a Principal Market, the highest reported
bid price for the Common Stock, as furnished by the National Association of
Securities Dealers, Inc, for the five trading days immediately preceding such
date.

         Section 1.5 "Closing" shall mean one of the closings of a purchase and
sale of the Debentures pursuant to Section 2.1.

<PAGE>

         Section 1.6 "Commitment Amount" shall mean the $10,000,000 up to which
the Investor has agreed to provide to the Company in order to purchase the
Debentures pursuant to the terms and conditions of this Agreement.

         Section 1.7 "Commitment Period" shall mean the period commencing on the
earlier to occur of the Effective Date, or (ii) such earlier date as the Company
and the Investor may mutually agree in writing, and expiring on the earliest to
occur of (x) the date on which the Investor shall have purchased Debentures
pursuant to this Agreement in the amount of at least $10,000,000 unless such
date is extended by the Investor, (y) the date this Agreement is terminated
pursuant to Section 2.4, or (z) September 1, 2003.

         Section 1.8 "Common Stock" shall mean the Company's common stock, par
value $0.001 per share.

         Section 1.9 "Condition Satisfaction Date" shall have the meaning set
forth in Section 7.2.

         Section 1.10 "Damages" shall mean any loss, claim, damage, liability,
costs and expenses (including, without limitation, reasonable attorney's fees
and disbursements and costs and expenses of expert witnesses and investigation).

         Section 1.11 "Debentures" shall mean the Debenture in the form of
Exhibit C annexed hereto.

         Section 1.12 "Effective Date" shall mean the date on which the SEC
first declares effective a Registration Statement registering the resale of the
Registrable Securities as set forth in Section 7.2(a).

         Section 1.13 "Escrow Agent" shall be First Union National Bank or its
successors.

         Section 1.14 "Escrow Agreement" shall mean the document which is
annexed hereto and referenced in Section 7.2 Subparagraph J of this Agreement.

         Section 1.15 "Exchange Act" shall mean the Securities Exchange Act of
1934, as amended, and the rules and regulations promulgated there under.

         Section 1.16 "Legend" shall mean that "legend" as set forth in Section
9.1.

         Section 1.17 "Material Adverse Effect" shall mean any effect on the
business, operations, properties, prospects, or financial condition of the
Company that is material and adverse to the Company and its subsidiaries and
affiliates, taken as a whole, and/or any condition, circumstance, or situation
that would prohibit or otherwise materially interfere with the ability of the
Company to enter into and perform any of its obligations under this Agreement,
the Debenture, the Registration Rights Agreement or the Escrow Agreement in any
material respect.

                                       2

<PAGE>

         Section 1.18 "Maximum Advance Amount" on any Advance Date shall be
equal to the difference between (i) the amount indicated opposite the range of
the 30 Day Average Daily Trading Volume on such Advance Date, as set forth in
the table below and (ii) the sum of the Advances made pursuant to this
Agreement, in the 30 calendar days immediately preceding the Advance Notice:

         30-Day Average Daily Trading (1)             Maximum Advance Amount (2)
         --------------------------------             --------------------------

         $25,000 - $50,000                                     $100,000
         $50,001 - $100,000                                    $200,000
         $100,001 - $200,000                                   $350,000
         $200,001 - $300,000                                   $500,000
         $300,001-$400,000                                     $650,000
         $400,001-$500,000                                     $900,000
         $500,001-$600,000                                     $1,200,000
         $600,001-$800,000                                     $1,500,000
         $800,001-$1,000,000                                   $1,750,000
         $1,000,000 and Over                                   $2,000,000

(1) The 30-Day Average Trading Volume shall be equal to the average of the Bid
Price multiplied by the volume for each of the 30 calendar days preceding the
Advance Date.

(2) Assuming that no Advances have been made pursuant to this Agreement during
the preceding 30 calendar days.

         Section 1.19 "NASD" shall mean the National Association of Securities
Dealers, Inc.

         Section 1.20 "Person" shall mean an individual, a corporation, a
partnership, an association, a trust or other entity or organization, including
a government or political subdivision or an agency or instrumentality thereof.

         Section 1.21 "Principal Market" shall mean the Nasdaq National Market,
the Nasdaq SmallCap Market, Bulletin Board, Over the Counter Market, the
American Stock Exchange or the New York Stock Exchange, whichever is at the time
the principal trading exchange or market for the Common Stock.

         Section 1.22 "Registrable Securities' shall mean the shares of Common
Stock (i) in respect of which the Registration Statement has not been declared
effective by the SEC, (ii) which have not been sold under circumstances under
which all of the applicable conditions of Rule 144 (or any similar provision
then in force) under the Securities Act ("Rule 144") are met or (iii) which have
not been otherwise transferred to holder who may trade such shares without
restriction under the Securities Act, and the Company has delivered a new
certificate or other evidence of ownership for such securities not bearing a
restrictive legend.

         Section 1.23 "Registration Rights Agreement" shall mean the agreement
regarding the filing of the Registration Statement for the resale of the
Registrable Securities, entered into between the Company and the Investor on the
Subscription Date annexed hereto as Exhibit D.

                                       3

<PAGE>

         Section 1.24 "Registration Statement" shall mean a registration
statement on Form S-3 (if use of such form is then available to the Company
pursuant to the rules of the SEC and, if not, on such other form promulgated by
the SEC for which the Company then qualifies and which counsel for the Company
shall deem appropriate, and which form shall be available for the resale of the
Registrable Securities to be registered there under in accordance with the
provisions of this Agreement and the Registration Rights Agreement, and in
accordance with the intended method of distribution of such securities), for the
registration of the resale by the Investor of the Registrable Securities under
the Securities Act.

         Section 1.25 "Regulation D" shall have the meaning set forth in the
recitals of this Agreement.

         Section 1.26 "SEC" shall mean the Securities and Exchange Commission.

         Section 1.27 "Section 4(2)" shall have the meaning set forth in the
recitals of this Agreement.

         Section 1.28 "Securities Act" shall have the meaning set forth in the
recitals of this Agreement.

         Section 1.29 "SEC Documents" shall mean the Form 10-K, Form 10-Q, Form
8-K, Proxy Statements, Registration Statements of the Company as supplemented to
the date hereof, filed by the Company for a period of at twelve (12) months
immediately preceding the date hereof or the Advance Date, as the case may be,
until such time as the Company no longer has an obligation to maintain the
effectiveness of a Registration Statement as set forth in the Registration
Rights Agreement.

         Section 1.30 "Subscription Date" shall mean the date on which this
Agreement is executed and delivered by the parties hereto.

         Section 1.31 "Trading Day" shall mean any day during which the New York
Stock Exchange shall be open for business.

                                   ARTICLE II

                                    Advances

         Section 2.1       Investments.

                 (a) Advances. Upon the terms and conditions set forth herein
(including without limitation, the provisions of Article VII hereof), on any
Advance Date the Company may request an Advance by the Investor by the delivery
of an Advance Notice. The amount of the Debenture that the Investor shall
receive pursuant to such Advance shall be equal to the amount of the Advance
specified in the Advance Notice, which Advance shall not exceed the Maximum
Advance Amount on such date.

                                       4

<PAGE>

         Section 2.2       Mechanics.

                 (a) Advance Notice. Every fifteen (15) days during the
Commitment Period, the Company may deliver an Advance Notice to the Investor,
subject to the conditions set forth in Section 2.4; provided, however, the
amount for each Advance as designated by the Company in the applicable Advance
notice shall not be (i) less than $100,000, or (ii) more than the Maximum
Advance Amount. The aggregate amount of the Advances pursuant to this Agreement
shall not exceed the Commitment Amount, unless otherwise agreed by the Investor
in the Investors sole and absolute discretion.

                 (b) Date of Delivery of Advance Notice. An Advance Notice shall
be deemed delivered on (i) the business Day it is received by facsimile or
otherwise by the Investor if such notice is received prior to 12:00 noon Eastern
Time, or (ii) the immediately succeeding Trading Day if it is received by
facsimile or otherwise after 12:00 noon Eastern Time on a Trading Day or at any
time on a day which is not a Trading Day. No Advance Notice may be deemed
delivered, on a day that is not a Trading Day.

         Section 2.3 Closings. On each Advance Date for an Advance, which shall
be within twenty (20) Trading Days of an Advance Notice, (i) the Company shall
deliver to the Escrow Agent one or more Debentures at the Investors option,
representing the amount of the Advance by the Investor pursuant to Section 2.1
herein, registered in the name of the Investor and (ii) the Investor shall
deliver to escrow the amount of the Advance specified in the Advance Notice by
wire transfer of immediately available funds to the Escrow Agent on or before
the Advance Date. In addition, on or prior to the Advance Date, each of the
Company and the Investor shall deliver to the Escrow Agent all documents,
instruments and writings required to be delivered or reasonably requested by
either of them pursuant to this Agreement in order to implement and effect the
transactions contemplated herein. Payment of funds to the Company and delivery
of the Debentures to the Investor shall occur out of escrow in accordance with
the conditions set forth above and those contained in the Escrow Agreement
referred to in Section 7.2(j); provided, however, that to the extent the Company
has not paid the fees, expenses, and disbursements of the Investors counsel,
Escrow Agent, and the Placement Agent in accordance with Section 13.4, the
amount of such fees, expenses, and disbursements must be paid by the Company in
immediately available funds from the Amount of the Advance held by the Escrow
Agent, at the direction of the Investor, to Investor's counsel, the Escrow
Agent, and the Placement Agent with no reduction in the amount of Debenture on
such Advance Date.

         Section 2.4 Termination of Investment. The obligation of the Investor
to make an Advance to the Company pursuant to this Agreement shall terminate
permanently (including with respect to an Advance Date that has not yet
occurred) in the event that (i) there shall occur any stop order or suspension
of the effectiveness of the Registration Statement for an aggregate of twenty
(20) Trading Days during the Commitment Period, for any reason other than
deferral or suspensions in

                                       5

<PAGE>

accordance with the Registration Rights Agreement as a result of corporate
developments subsequent to the Subscription Date that would require such
Registration Statement to be amended to reflect such event in order to maintain
its compliance with the disclosure requirements of the Securities Act or (ii)
the Company shall at any time fail materially to comply with the requirements of
Section 6.3, 6.4 or 6.6.

         Section 2.5       Agreement to Advance Funds.

                 (a) The Investor agrees to advance the amount specified in the
Advance Notice to the Company within twenty (20) business Days after the
completion of each of the following conditions and the other conditions set
forth in this Agreement:

                 (i) the execution and delivery by the Company, and the
         Investor, or this Agreement, and all Exhibits and Attachments hereto;

                 (ii) delivery into escrow by the Company of the original
         Debenture;

                 (iii) the Company's Registration Statement with respect to the
         resale of the Registrable Securities in accordance with the terms of
         the Registration Rights Agreement shall have been declared effective by
         the SEC;

                 (iv) the Company shall have obtained all permits and
         qualifications required by any applicable state for the offer and sale
         of the Registrable Securities, or shall have the availability of
         exemptions therefrom. The sale and issuance of the Registrable
         Securities shall be legally permitted by all laws and regulations to
         which the Company is subject; and

                 (v) payment of fees as set forth in Section 13.4 below.

                                   ARTICLE III

                   Representations and Warranties of Investor

         Investor represents and warrants to, and agrees with, the Company that:

         Section 3.1 Organization and Authorization. Investor is duly
incorporated or organized and validly existing in the jurisdiction of its
incorporation or organization and has all requisite power and authority to
purchase and hold the securities issuable hereunder. The decision to invest and
the execution and delivery of this Agreement by such Investor, the performance
by such Investor of its obligations hereunder and the consummation by such
Investor of the transactions contemplated hereby have been duly authorized and
requires no other proceedings on the part of the Investor. The undersigned has
all right, power and authority to execute and deliver this Agreement and all
other instruments ( including, without limitations, the Registration Rights
Agreement), on behalf of the Investor. This Agreement has been duly executed and
delivered by the Investor and, assuming the execution and delivery hereof and
acceptance thereof by the Company, will constitute the legal, valid and binding
obligations of the Investor, enforceable against the Investor in accordance with
its terms.

                                       6

<PAGE>

         Section 3.2 Evaluation of Risks. The Investor has such knowledge and
experience in financial tax and business matters as to be capable of evaluating
the merits and risks of, and bearing the economic risks entailed by, an
investment in the Company and of protecting its interests in connection with
this transaction. It recognizes that its investment in the Company involves a
high degree of risk. The Investor acknowledges that it has been furnished with,
and has carefully read the applicable form of Debenture and form of Registration
Rights Agreement.

         Section 3.3 Independent Counsel. The Investor acknowledges that it has
been advised to consult with its own attorney regarding legal matters concerning
the Company and to consult with its tax advisor regarding the tax consequences
of acquiring the Debentures issuable hereunder.

         Section 3.4 No Registration. The Investor understands that the
Debenture and Common Stock underlying the Debenture issuable hereunder have not
been registered under the Act or any other securities laws but are being offered
and sold to it in reliance upon specific exemptions from the registration
requirements of Federal and State securities laws and that the Company is
relying upon the truth and accuracy of the representations, warranties,
agreements, acknowledgments and understandings of the Investor set forth herein
in order to determine the applicability of such exemptions and the suitability
of the Investor to acquire the securities hereunder.

         Section 3.5 Investment Purpose. The Debentures are being purchased by
the Investor for its own account, for investment and without any view to the
distribution, assignment or resale to others or fractionalization in whole or in
part. The Investor is neither an underwriter, nor a dealer in, the Debenture or
the Common Stock issuable on conversion thereof. The Investor agrees not to
assign or in any way transfer the Investors rights to the Debentures or any
interest therein and acknowledges that the Company will not recognize any
purported assignment or transfer. No other person has or will have a direct or
indirect beneficial interest in the sDebentures . The Investor agrees not to
sell, hypothecate or otherwise transfer the Investor's Debentures unless the
securities are registered under Federal and applicable state securities law or
unless, in the opinion of counsel satisfactory to the Company, an exemption from
such laws is available.

         Section 3.6 Accredited Investor Status. Each Investor is an "accredited
investor" as that term is defined in Rule 501(a)(3) of Regulation D.

         Section 3.7 Information. Such Investor and its advisors (and his or,
its counsel), if any, have been furnished with all materials relating to the
business, finances and operations of the Company and information he deemed
material to making an informed investment decision, which have been requested by
such Investor. Such Investor and its advisors, if any, have been afforded the
opportunity to ask questions of the Company and its management. Neither such
inquiries nor any other due diligence investigations conducted by such Investor
or its advisors, if any, or its representatives shall modify, amend or affect
such Investor's right to rely on the Company's representations and warranties
contained in Section 4 below. Such Investor understands that its

                                       7

<PAGE>

investment involves a high degree of risk. Investor is in a position regarding
the Company, which, based upon employment, family relationship or economic
bargaining power, enabled and enables Investor to obtain information from the
Company in order to evaluate the merits and risks of this investment. Such
Investor has sought such accounting, legal and tax advice, as it has considered
necessary to make an informed investment decision with respect to this
transaction.

         Section 3.8 Receipt of Documents. Such Investor and his or its counsel
has received and read in their entirety: (i) this Agreement and each
representation, warranty and covenant set forth herein, the Certificate of
Designations, and the Escrow Agreement; (ii) all due diligence and other
information necessary to verify the accuracy and completeness of such
representations, warranties and covenants; (iii) the Company's Form 10-KSB for
the year ended 1999; (iv) the Company's Forms 10-QSB for the periods ended June
30, 2000; and (v) the Company's Form 8-K filed sinces January 1, 2000 and (iv)
answers to all questions the Investor submitted to the Company regarding an
investment in the Company; and the Investor has relied on the information
contained therein and has not been furnished any other documents, literature,
memorandum or prospectus.

         Section 3.9 Registration Rights. The parties have entered into the
Registration Rights Agreement.

         Section 3.9 No Advertisements. The Investor is not entering into this
Agreement as a result of or subsequent to any advertisement, article, notice or
other communication published in any newspaper, magazine, or similar media or
broadcast over television or radio, or presented at any seminar or meeting.

         Section 3.10 Not an Affiliate. The Investor is not an officer, director
or "affiliate" (as that term is defined in Rule 405 of the Securities Act) of
the Company. The Investor agrees that following the date of the Agreement it
will not, and will cause its Affiliates not to engage in any short sales, swaps,
purchasing of puts, or other hedging activities with respect to the Common Stock
or any activity that involves the direct or indirect use of Common Stock to
hedge its investment in the Debentures until the expiration of the conversion
period of the Debentures.

         Section 3.11 Authorization, Enforcement. This Agreement has been duly
and validly authorized, executed and delivered on behalf of such Investor and is
a valid and binding agreement of such Investor enforceable in accordance with
its terms, except as such enforceability may be limited by general principles of
equity and to applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation and other similar laws relating to, or affecting generally, the
enforcement of applicable creditors' rights and remedies.

         Section 3.12 Due Formation of Corporate and Other Investors. If the
Investor is a corporation, trust, partnership or other entity that is not an
individual person, it has been formed and validly exists and has not been
organized for the specific purpose of this transaction and is not prohibited
from doing so.

                                       8

<PAGE>

         Section 3.13 Due Authorization of Fiduciary Investors. If the Investor
is purchasing the Debentures in a fiduciary capacity for another person or
entity, including without limitation a corporation, partnership, trust or any
other entity, the Investor has been duly authorized and empowered to execute
this Agreement and such other person fulfills all the requirements for this
transaction and agrees to be bound by the obligations, representations,
warranties, and covenants contained herein. Upon request of the Company, the
Investor will provide true, complete and current copies of all relevant
documents creating the Investor, authorizing its investment in the Company
and/or evidencing the satisfaction of the foregoing.

         Section 3.14 Further Representations by Foreign Investors. If Investor
is not a U.S. Person (as defined), such Investor hereby represents that such
Investor is satisfied as to full observance of the laws of such Investor
jurisdiction in connection with any invitation to subscribe for the securities
or any use of this Agreement, including: (i) the legal requirements of such
Investor's jurisdiction for the purchase of the Debentures, (ii) any foreign
exchange restrictions applicable to such purchase, (iii) any governmental or
other consents that may need to be obtained, and (iv) the income tax and other
tax consequences, if any, which may be relevant to the purchase, holding,
redemption, sale, or transfer of the Debentures. Such Investor's and payment
for, and such Investor's continued beneficial ownership of, the Debentures will
not violate any applicable securities or other laws of such Investor's
jurisdiction. The term "U.S. Person" as used herein shall mean any person who is
a citizen or resident of the United States or Canada, or any state, territory or
possession thereof, including but not limited to any estate of any such person,
or any corporation, partnership, trust or other entity created or existing under
the laws thereof, or any entity controlled or owned by any of the foregoing.

                                   ARTICLE IV
                  Representations and Warranties of the Company

         Except as stated below or in the SEC Documents, the Company hereby
represents and warrants to, and covenants with, the Investors that the following
are true and correct as of the date hereof and as of the Advance Date:

         Section 4.1 Organization and Qualification. The Company and its
subsidiaries are corporations duly organized and validly existing in good
standing under the laws of the jurisdictions in which they are incorporated, and
have the requisite corporate power to own their properties and to carry on their
business as now being conducted. Each of the Company and its subsidiaries is
duly qualified as a foreign corporation to do business and is in good standing
in every jurisdiction in which the nature of the business conducted by it makes
such qualification necessary, except to the extent that the failure to be so
qualified or be in good standing would not have a material adverse effect on the
Company and its subsidiaries taken as a whole.

                                       9

<PAGE>

         Section 4.2 Authorization, Enforcement, Compliance with Other
Instruments. (i) The Company has the requisite corporate power and authority to
enter into and perform this Agreement, the Registration Rights Agreement and any
related agreements, and to consummate the transactions contemplated hereby in
accordance with the terms hereof and thereof, (ii) the execution and delivery of
this Agreement, the Registration Rights Agreement and any related agreements by
the Company and the consummation by it of the transactions contemplated hereby
and thereby, shares of Common Stock upon the conversion of the Debentures (the
"Debenture Shares"), have been duly authorized by the Company's Board of
Directors and no further consent or authorization is required by the Company,
its Board of Directors or its stockholders, (iii) this Agreement and the
Registration Rights Agreement and any related agreements have been duly executed
and delivered by the Company, (iv) this Agreement, the Registration Rights
Agreement and any related agreements constitute the valid and binding
obligations of the Company enforceable against the Company in accordance with
their terms, except as such enforceability may be limited by general principles
of equity or applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally, the enforcement
of creditors' rights and remedies.

         Section 4.3 Capitalization. As of the date hereof, the authorized
capital stock of the Company consists of 100,000,000 shares of Common Stock, par
value $0.001 per share, and 25,000,000 shares of Preferred Stock, $0.001 per
share of which as of June 6, 2000, 30,423,196 shares of Common Stock and 2,000
shares of Preferred Stock were issued and outstanding. All of such outstanding
shares have been validly issued and are fully paid and nonassessable. Except as
disclosed in Schedule 3(c), no shares of Common Stock are subject to preemptive
rights or any other similar rights or any liens or encumbrances suffered or
permitted by the Company. Except as disclosed in Schedule 3(c), as of the date
of this Agreement, (i) there are no outstanding options, warrants, scrip, rights
to subscribe to, calls or commitments of any character whatsoever relating to,
or securities or rights convertible into, any shares of capital stock of the
Company or any of its subsidiaries, or contracts, commitments, understandings or
arrangements by which the Company or any of its subsidiaries is or may become
bound to issue additional shares of capital stock of the Company or any of its
subsidiaries or options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company or any of its
subsidiaries, (ii) there are no outstanding debt securitiesexcept as are related
to certain Agreements executed by the Company on August 28, 2000 relating to
Convertible Debentures and Warrants and (iii) there are no agreements or
arrangements under which the Company or any of its subsidiaries is obligated to
register the sale of any of their securities under the 1933 Act (except pursuant
to the Registration Rights Agreements). There are no securities or instruments
except as described in this Agreement, and in certain Securities Purchase
Agreement dated August 28, 2000, there are not securities or instruments
containing anti-dilution or similar provisions that would be triggered by the
issuance of Debentures. the Warrants, or the Warrant Shares as described in this
Agreement. The Company has furnished to the Investors true and correct copies of
the Company's Certificate of Incorporation, as amended and as in effect on the
date hereof (the "Certificate of Incorporation"), and the Company's By-laws, as
in effect on the date hereof (the "By-laws"), and the terms of all securities
convertible into or exercisable for Common Stock and the material rights of the
holders thereof in respect thereto.

                                       10

<PAGE>

         Section 4.4 No Conflict. Except as described in the SEC Documents or in
this Agreement and schedule 3(e) the execution, delivery and performance of this
Agreement by the Company and the consummation by the Company of the transactions
contemplated hereby will not (i) result in a violation of the Certificate of
Incorporation, or By-laws or (ii) conflict with or constitute a default (or an
event which with notice or lapse of time or both would become a default) under,
or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, indenture or instrument to which the Company or
any of its subsidiaries is a party, or result in a violation of any law, rule,
regulation, order, judgment or decree (including federal and state securities
laws and regulations and the rules and regulations of The Nasdaq Stock Market
Inc.'s OTC Bulletin Board on which the Common Stock is quoted) applicable to the
Company or any of its subsidiaries or by which any property or asset of the
Company or any of its subsidiaries is bound or affected. Except as disclosed in
Disclosure Schedule, neither the Company nor its subsidiaries is in violation of
any term of or in default under its Certificate of Incorporation or By-laws or
their organizational charter or by-laws, respectively, or any material contract,
agreement, mortgage, indebtedness, indenture, instrument, judgment, decree or
order or any statute, rule or regulation applicable to the Company or its
subsidiaries. The business of the Company and its subsidiaries is not being
conducted, and shall not be conducted in violation of any material law,
ordinance, regulation of any governmental entity. Except as specifically
contemplated by this Agreement and as required under the 1933 Act and any
applicable state securities laws, the Company is not required to obtain any
consent, authorization or order of, or make any filing or registration with, any
court or governmental agency in order for it to execute, deliver or perform any
of its obligations under or contemplated by this Agreement or the Registration
Rights Agreement in accordance with the terms hereof or thereof. Except as
disclosed in the SEC Documents e , all consents, authorizations, orders, filings
and registrations which the Company is required to obtain pursuant to the
preceding sentence have been obtained or effected on or prior to the date
hereof. The Company and its subsidiaries are unaware of any facts or
circumstance, which might give rise to any of the foregoing.

         Section 4.6 No Default. Except as described in the SEC Documents or in
this Agreement , the Company is not in default in the performance or observance
of any material obligation, agreement, covenant or condition contained in any
indenture, mortgage, deed of trust or other material instrument or agreement to
which it is a party or by which it is or its property is bound and neither the
execution, nor the delivery by the Company, nor the performance by the Company
of its obligations under this Agreement or any of the Exhibits or attachments
hereto, including the conversion provision of the Debentures, will conflict with
or result in the breach or violation of any of the terms or provisions of, or
constitute a default or result in the creation or imposition of any lien or
charge on any assets or properties of the Company under, any material indenture,
mortgage, deed of trust or other material agreement applicable to the Company or
instrument to which the Company is a party or by which it is bound, other than
anti-dilution provisions of certain agreements and instruments with respect to
warrants and other Common Stock equivalents, or any statute or the memorandum or
Articles of the Company or any decree, judgment, order rules of regulation of
any court or governmental agency or body having jurisdiction over the Company or
its properties, in each case which default, lien or charge is likely to cause a
material adverse effect on the Company"s business and financial condition.

                                       11

<PAGE>

         Section 4.7 Absence of Events of Default. Except for matters described
in the SEC Documents and/or this Agreement, no Event of Default, as defined in
the respective agreement to which the Company is a party, and no event which,
with the giving of notice or the passage of time or both, would become an Event
of Default (as so defined), has occurred and is continuing, which would have a
material adverse effect on the Company's business, properties, prospects,
financial condition or results of operations.

         Section 4.8 Governmental Consent, etc. Except for matters described in
the SEC Documents or in this Agreement , no consent, approval or authorization
of or designation, declaration or filing with any governmental authority on the
part of the Company is required in connection with the valid execution and
delivery of this Agreement, or the offer, sale or issuance of the Debentures
hereunder, or the consummation of any other transaction contemplated hereby.

         Section 4.9 Intellectual Property Rights. The Company and its
subsidiaries own or possess adequate rights or licenses to use all trademarks,
trade names, service marks, service mark registrations, service names, patents,
patent rights, copyrights, inventions, licenses, approvals, governmental
authorizations, trade secrets and rights necessary to conduct their respective
businesses as now conducted. Except as set forth on Schedule 3(n) and the SEC
Documents, none of the Company's trademarks, trade names, service marks, service
mark registrations, service names, patents, patent rights, copyrights,
inventions, licenses, approvals, government authorizations, trade secrets, or
other intellectual property rights have expired or terminated, or are expected
to expire or terminate in the near future. Except as disclosed in the SEC
Documents or this Agreement the Company and its subsidiaries do not have any
knowledge of any infringement by the Company or its subsidiaries of trademark,
trade name rights, patents, patent rights, copyrights, inventions, licenses,
service names, service marks, service mark registrations, trade secret or other
similar rights of others, or of any such development of similar or identical
trade secrets or technical information by others and, except as set forth on
Schedule 3(n), to the knowledge of the Company, there is no claim, action or
proceeding being made or brought against, or to the Company's knowledge, being
threatened against, the Company or its subsidiaries regarding trademark, trade
name, patents, patent rights, invention, copyright, license, service names,
service marks, service mark registrations, trade secret or other infringement;
and the Company and its subsidiaries are unaware of any facts or circumstances
which might give rise to any of the foregoing. The Company and its subsidiaries
have taken reasonable security measures to protect the secrecy, confidentiality
and value of all of their intellectual properties.

         Section 4.10 Employee Relations. Neither the Company nor any of its
subsidiaries is involved in any labor dispute nor, to the knowledge of the
Company or any of its subsidiaries, is any such dispute threatened. None of the
Company's or its subsidiaries' employees is a member of a union and the Company
and its subsidiaries believe that their relations with their employees are good.

                                       12

<PAGE>

         Section 4.11 Environmental Laws. The Company and its subsidiaries are
(i) in compliance with any and all applicable foreign, federal, state and local
laws and regulations relating to the protection of human health and safety, the
environment or hazardous or toxic substances or wastes, pollutants or
contaminants ("Environmental Laws"), (ii) have received all permits, licenses or
other approvals required of them under applicable Environmental Laws to conduct
their respective businesses and (iii) are in compliance with all terms and
conditions of any such permit, license or approval.

         Section 4.12 Title. The Company and its subsidiaries have good and
marketable title in fee simple to all real property and good and marketable
title to all personal property owned by them which is material to the business
of the Company and its subsidiaries, in each case free and clear of all liens,
encumbrances and defects except such as are described in Schedule 3(p), are
disclosed in the SEC Documents or such as do not materially affect the value of
such property and do not interfere with the use made and proposed to be made of
such property by the Company and its subsidiaries. Any real property and
facilities held under lease by the Company and its subsidiaries are held by them
under valid, subsisting and enforceable leases with such exceptions as are not
material and do not interfere with the use made and proposed to be made of such
property and buildings by the Company and its subsidiaries.

         Section 4.13 Insurance. The Company and each of its subsidiaries are
insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as management of the Company believes to be
prudent and customary in the businesses in which the Company and its
subsidiaries are engaged. Neither the Company nor any such subsidiary has been
refused any insurance coverage sought or applied for and neither the Company nor
any such subsidiary has any reason to believe that it will not be able to renew
its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its
business at a cost that would not materially and adversely affect the condition,
financial or otherwise, or the earnings, business or operations of the Company
and its subsidiaries, taken as a whole.

         Section 4.14 Regulatory Permits. The Company and its subsidiaries
possess all certificates, authorizations and permits issued by the appropriate
federal, state or foreign regulatory authorities necessary to conduct their
respective businesses, and neither the Company nor any such subsidiary has
received any notice of proceedings relating to the revocation or modification of
any such certificate, authorization or permit.

         Section 4.15 Internal Accounting Controls. The Company and each of its
subsidiaries maintain a system of internal accounting controls sufficient to
provide reasonable assurance that (i) transactions are executed in accordance
with management's general or specific authorizations, (ii) transactions are
recorded as necessary to permit preparation of financial statements in
conformity with generally accepted accounting principles and to maintain asset
accountability, (iii) access to assets is permitted only in accordance with
management's general or specific authorization and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.

                                       13

<PAGE>

         Section 4.16 No Materially Adverse Contracts, etc. Except as set forth
in the SEC Documents and this Agreement, neither the Company nor any of its
subsidiaries is subject to any charter, corporate or other legal restriction, or
any judgment, decree, order, rule or regulation which in the judgment of the
Company's officers has or is expected in the future to have a material adverse
effect on the business, properties, operations, financial condition, results of
operations or prospects of the Company or its subsidiaries. Neither the Company
nor any of its subsidiaries is a party to any contract or agreement which in the
judgment of the Company's officers has or is expected to have a material adverse
effect on the business, properties, operations, financial condition, results of
operations or prospects of the Company or its subsidiaries.

         Section 4.17 Litigation. Except as disclosed in the SEC Docuiments
and/or Schedule 3(i),there is no action, suit, proceeding, inquiry or
investigation before or by any court, public board, government agency,
self-regulatory organization or body pending or, to the knowledge of the Company
or any of its subsidiaries, threatened against or affecting the Company, the
Common Stock or any of the Company's subsidiaries, wherein an unfavorable
decision, ruling or finding would (i) have a material adverse effect on the
transactions contemplated hereby (ii) adversely affect the validity or
enforceability of, or the authority or ability of the Company to perform its
obligations under, this Agreement or any of the documents contemplated herein,
or (iii) except as expressly disclosed in the SEC Documents, have a material
adverse effect on the business, operations, properties, financial condition or
results of operation of the Company and its subsidiaries taken as a whole.

         Section 4.18 Title to Assets. Except as set forth in the SEC Documents,
the Company has good and marketable title to all properties and material assets
described in the SEC Documents as owned by it, free and clear of any pledge,
lien, security interest, encumbrance, claim or equitable interest other than
such as are not material to the business of the Company.

         Section 4.19 Subsidiaries. Except for entities formed or being formed
involving the Company's European business, as disclosed in the SEC Documents,
the Company does not presently own or control, directly or indirectly, any
interest in any other corporation, partnership, association or other business
entity.

         Section 4.20 Required Governmental Permits. Except as set forth in the
SEC Documents, the Company is in possession of and operating in compliance with
all authorizations, licenses, certificates, consents, orders and permits from
state, federal and other regulatory authorities which are material to the
conduct of its business, all of which are valid and in full force and effect.

         Section 4.21 Other Outstanding Securities/Financing Restrictions. As of
the date hereof only, other than warrants and options to acquire shares of
Common Stock as disclosed in the SEC Documents or in this Agreement, there are
no other warrants and options registered with the SEC, which are available for
sale as unrestricted ("free trading") stock.

                                       14

<PAGE>

         Section 4.22 Use of Proceeds. The Company represents that the net
proceeds from this offering will be used for mergers and acquisitions of assets
in connection with strategic partnerships or joint ventures and associated costs
and expenses. However, in no event shall the net proceeds from this offering be
used by the Company for the payment (or loaned to any such person for the
payment) of any judgment, or other liability, incurred by any executive officer,
officer, director, or employee of the Company.

         Section 4.23 Further Representation and Warranties of the Company. For
so long as any securities issuable hereunder held by the Investor remain
outstanding, the Company acknowledges, represents, warrants and agrees that it
will use commercially reasonable efforts to maintain the listing of its Common
Stock on the NASDAQ Small Cap Stock Market and/or NASDAQ Bulletin Board and/or
the Over the Counter Market.

         Section 4.24 SEC Filings/Full Disclosre. The Company has filed all
reports, schedules, forms, statements and other documents required to be filed
by it with the SEC under of the Securities Exchange Act of 1934, as amended (the
"1934 Act") (all of the foregoing filed prior to the date hereof and all
exhibits included therein and financial statements and schedules thereto and
documents incorporated by reference therein, being referred to in this Agreement
as the "SEC Documents". The Company has delivered to the Investors or their
representatives, or made available through the SEC's website at
http://www.sec.gov., true and complete copies of the SEC Documents. As of their
respective dates, the financial statements of the Company disclosed in the SEC
Documents (the "Financial Statements") complied as to form in all material
respects with applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto. Such financial statements have been
prepared in accordance with generally accepted accounting principles,
consistently applied, during the periods involved (except (i) as may be
otherwise indicated in such financial statements or the notes thereto, or (ii)
in the case of unaudited interim statements, to the extent they may exclude
footnotes or may be condensed or summary statements) and fairly present in all
material respects the financial position of the Company as of the dates thereof
and the results of its operations and cash flows for the periods then ended
(subject, in the case of unaudited statements, to normal year-end audit
adjustments). No other information provided by the Company to the Investor which
is not included in the SEC Documents, contains any untrue statement of a
material fact or omits to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were
made, not misleading.

         Section 4.25 Full Disclosure. There is no fact known to the Company
(other than general economic conditions known to the public generally) that has
not been disclosed in writing to the Investor that (i) could reasonably be
expected to have a material adverse effect on the financial condition or in the
earnings, business affairs, business prospects, properties or assets of the
Company, or (ii) could reasonably be expected to materially and adversely affect
the ability of the Company to perform its obligations pursuant to this
Agreement.

         Section 4.26 Opinion of Counsel. Investor shall receive an opinion
letter from counsel to the Company (updated where applicable) prior to each
Closing substantially to the effect that:

                                       15

<PAGE>

                  (a) the Company is incorporated and validly existing in the
jurisdiction of its incorporation. The Company and/or its subsidiaries are duly
qualified to do business as a foreign corporation and is in good standing in all
jurisdictions where, to such counsel's knowledge, the Company and/or its
subsidiaries owns or leases properties, maintains employees or conducts
business, except for jurisdictions in which the failure to so qualify would not
have a material adverse effect on the Company, and has all requisite corporate
power and authority to own its properties and conduct its business.

                  (b) to such counsel's knowledge, except for matters disclosed
in the SEC Documents, there is no action, proceeding or investigation pending,
or threatened against the Company which might result, either individually or in
the aggregate, in any material adverse change in the business or financial
condition of the Company.

                  (c) to such counsel's knowledge, except for matters disclosed
in the SEC Documents, the Company is not a party to or subject to the provisions
of any order, writ, injunction, judgment or decree of any court or government
agency or instrumentality.

                  (d) the shares of Common Stock issuable upon the conversion of
         the Debentures, based on the Bid Price on the day of such closing, have
         been duly authorized and upon issuance will be validly issued under the
         laws of the Company's state of incorporation.

                  (e) this Agreement, the issuance of the Debentures hereunder,
and the shares of Common Stock issuable upon conversion of the Debentures, have
been duly approved by all required corporate action and that all such shares of
Common Stock, upon execution and delivery that shall be validly issued and
outstanding, fully paid and nonassessable.

                  (f) the issuance of the Debentures and the shares of Common
Stock issuable upon conversion thereof, does not violate the applicable listing
agreement between the Company and any securities exchange or market on which the
Company's securities are listed.

                  (g) the authorized capital stock of the Company consists of
100,000,000 shares of Common Stock, $0.001 par value per share, and 25,000,000
shares of preferred stock.

                  (h) the Common Stock is registered pursuant to Section 12(g)
of the Securities and Exchange Act of 1934

         Section 4.27 Opinion of Counsel. The Company will obtain for the
Investor, at the Company's expense, any and all opinions of counsel which may be
reasonably required in order to convert, exercise or sell the Debentures
issuable hereunder, including, but not limited to, obtaining for Investors, at
the Company's expense an opinion of counsel, subject only to receipt of a Notice
of Conversion in the form of Exhibit F, duly executed by the Investor which
shall be satisfactory to the Transfer Agent, directing the Transfer Agent to
remove the self-liquidating legend.

         Section 4.28 Dilution. The Company is aware and acknowledges that
conversion of the Debentures could cause dilution to existing shareholder and
could significantly increase the outstanding number of shares of Common Stock.

                                       16

<PAGE>

         Section 4.29 Tax Status. The Company and each of its subsidiaries has
made or filed all federal and state income and all other tax returns, reports
and declarations required by any jurisdiction to which it is subject (unless and
only to the extent that the Company and each of its subsidiaries has set aside
on its books provisions reasonably adequate for the payment of all unpaid and
unreported taxes) and has paid all taxes and other governmental assessments and
charges that are material in amount, shown or determined to be due on such
returns, reports and declarations, except those being contested in good faith
and has set aside on its books provision reasonably adequate for the payment of
all taxes for periods subsequent to the periods to which such returns, reports
or declarations apply. There are no unpaid taxes in any material amount claimed
to be due by the taxing authority of any jurisdiction, and the officers of the
Company know of no basis for any such claim.

                                    ARTICLE V
           Representations and Warranties of the Company and Investor

         The Investor and the Company represent to the other the following with
respect to itself:

         Section 5.1 Line of Credit Agreement. This Agreement has been duly
authorized, validly executed and delivered on behalf of the Company and the
Investor and is a valid and binding agreement in accordance with its terms,
subject to general principles of equity and to bankruptcy or other laws
affecting the enforcement of creditors' rights generally.

         Section 5.2 Non-contravention. Subject to the exceptions referred to
elsewhere in this Agreement ( see SEC Documents) the execution and delivery of
this Agreement along with all Exhibits and Attachments, and the consummation of
the issuance of the Debturesand the transactions contemplated by this Agreement
do not and will not conflict with or result in a breach by the Company or the
Investor of any of the terms or provisions of, or constitute a default under,
the articles of incorporation or by-laws of the Company or the Investor, or any
indenture, mortgage, deed of trust of other material agreement or instrument to
which the Company or the Investor is a party or by which it or any of its
properties or assets are bound, or any existing applicable law, rule or
regulation or any applicable decree, judgment or order of any court, Federal or
State regulatory body, administrative agency or other governmental body having
jurisdiction over the Company or Investor or any of its properties or assets.

         Section 5.3 Approvals. Neither the Company nor Investor is aware of any
authorization, approval or consent of any governmental body which is legally
required for the issuance and sale of the Debentures.

                                       17

<PAGE>

         Section 5.4 Indemnification. Each of the Company and the Investors
agree to indemnify the other and to hold the other harmless from and against any
and all losses, damages, liabilities, costs and expenses (Including reasonable
attorneys fees) which the other may sustain or incur in connection with the
breach by the indemnifying party of any representation, warranty or covenant
made by it in this Agreement.

                                   ARTICLE VI
                            Covenants of the Company

         Section 6.1 Registration Rights. The Company shall cause the
Registration Rights Agreement to remain in full force and effect and the Company
shall comply in all material respects with the terms thereof.

         Section 6.2 Reservation of Common Stock. The Company shall authorize
and reserve and keep available at all times, free of preemptive rights, such
number of shares of Common Stock necessary in order to enable the Company to
satisfy any obligation to issue shares of Common Stock underlying the
Debentures, such number of shares of Common Stock to be reserved shall be
calculated based upon the Bid Price of the Common Stock from time to time while
such Debentures are outstanding. The number of shares so reserved from time to
time, while such Debentures are outstanding, as theretofore increased or reduced
as hereinafter provided, may be limited to shares issuable under outstanding
Debentures at the Bid Price reduced by the number of shares actually delivered
pursuant to the Debentures and the number of shares so reserved shall be
increased or decreased to reflect potential increases or decreases in the Common
Stock that the Company may thereafter be so obligated to issue.

         Section 6.3 Listing of Common Stock. The Company further agrees, if the
Company applies to have the Common Stock traded on any Principal Market, other
than the Nasdaq Small Cap Market, it will include in such application the shares
of Common Stock issuable upon the conversion of the Debentures and will take
such other action as is necessary or desirable in the opinion of the investor to
cause the Common Stock to be listed on such other Principal Market as promptly
as possible and will use commercially reasonable efforts to comply in all
respects with the Company's reporting, filing and other obligations under the
bylaws or rules of the Principal Market.

         Section 6.4 Exchange Act Registration. The Company will cause its
Common Stock to continue to be registered under Section 12(g) of the Exchange
Act, will use its best efforts to comply in all respects with its reporting and
filing obligations under the Exchange Act, and will not take any action or file
any document (whether or not permitted by Exchange Act or the rules there under
to terminate or suspend such registration or to terminate or suspend its
reporting and filing obligations under said Act.

         Section 6.5 Legends. The certificates evidencing the Common Stock to be
sold by the Investor shall bear the legend or a similar legend as set forth in
section 9.1, except as setforth herein.

         Section 6.6 Corporate Existence. The Company will take all steps
necessary to preserve and continue the corporate existence of the Company.

                                       18

<PAGE>

         Section 6.7 Notice of Certain Events Affecting Registration: Suspension
of Right to Make an Advance. The Company will immediately notify the Investor
upon its becoming aware of the occurrence of any of the following events in
respect of a registration statement or related prospectus relating to an
offering of Registrable Securities; (i) receipt of any request for additional
information by the SEC or any other federal or state governmental authority
during the period of effectiveness of the Registration Statement for amendments
or supplements to the registration statement or related prospectus; (ii) the
issuance by the SEC or any other federal or state governmental authority of any
stop order suspending the effectiveness of the Registration Statement or the
initiation of any proceedings for that purpose; (iii) receipt of any
notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any
jurisdiction or the initiation or threatening of any proceeding for such
purpose; (iv) subject to the Registration Rights Agreement the happening of any
event that makes any statement made in the Registration Statement or related
prospectus of any document incorporated or deemed to be incorporated therein by
reference untrue in any material respect or that requires the making of any
changes in the Registration Statement, related prospectus or documents so that,
in the case of the Registration Statement, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be
stated therein or necessary to make the statements therein not misleading, and
that in the case of the related prospectus, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be
stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; and (v) the Company's
reasonable determination that a post-effective amendment to the Registration
Statement would be appropriate; and the Company will promptly make available to
the Investor any such supplement or amendment to the related prospectus. The
Company shall not deliver to the Investor any Advance Notice during the
continuation of any of the foregoing events.

         Section 6.8 Expectations Regarding Advance Notices. Within ten (10)
days after the commencement of each calendar quarter occurring subsequent to the
commencement of the Commitment Period, the Company must notify the Investor, in
writing, as to its reasonable expectations as to the dollar amount it intends to
raise during such calendar quarter, if any, through the issuance of Advance
Notices. Such notification shall constitute only the Company's good faith
estimate and shall in no way obligate the Company to raise such amount, or any
amount, or otherwise limit its ability to deliver Advance Notices. The failure
by the Company to comply with this provision can be cured by the Company's
notifying the Investor, in writing, at any time as to its reasonable
expectations with respect to the current calendar quarter.

         Section 6.9 Consolidation: Merger. The Company shall not, at any time
after the date hereof, effect any merger or consolidation of the Company with or
into, or a transfer of all or substantially all the assets of the Company to
another entity (a "Consolidation Event") unless the resulting successor or
acquiring entity (if not the Company) assumes by written instrument the
obligation to deliver to the investor such shares of stock and/or securities as
the Investor is entitled to receive pursuant to this Agreement.

                                       19

<PAGE>

         Section 6.10 Issuance of Debentures. The sale of the Debentures and the
issuance of the shares of Commons Stock pursuant to conversion hereof shall be
made in accordance with the provision and requirements of Section 4(2) of the
Securities Act, or Regulation D and any applicable state securities law.

                                   ARTICLE VII
                Conditions for Advance and Conditions to Closing

         Section 7.1 Conditions Precedent to the Obligation of the Company to
Issue and Sell the Debentures. The obligation hereunder of the Company to issue
and sell the Debentures to the Investor incident to each Closing is subject to
the satisfaction, or waiver by the Company, at or before each such Closing, of
each of the conditions set forth below.

                  (a) Accuracy of the Investor's Representation and Warranties.
The representations and warranties of the Investor shall be true and correct in
all material respects as of the date of this Agreement and as of the date of
each such Closing as though made at each such time.

                  (b) Performance by the Investor. The Investor shall have
performed, satisfied and complied in all respects with all covenants, agreements
and conditions required by this Agreement to be performed, satisfied or complied
with by the Investor at or prior to such Closing.

         Section 7.2 Conditions Precedent to the Right of the Company to Deliver
an Advance Notice and the Obligation of the Investor to Purchase Debentures. The
right of the Company to deliver an Advance Notice and the obligation of the
Investor hereunder to acquire and pay for the Debentures incident to a Closing
is subject to the satisfaction or waiver by the Investor, on (i) the date of
delivery of such Advance Notice and (ii) the applicable Advance Date (each a
"Condition Satisfaction Date"), of each of the following conditions:

                  (a) Registration of the Common Stock with the SEC. The Company
shall have filed with the SEC a Registration Statement with respect to the
resale of the Registrable Securities in accordance with the terms of the
Registration Rights Agreement. As set forth in the Registration Rights
Agreement, the Registration Statement shall have previously become effective and
shall remain effective on each Condition Satisfaction Date and (i) neither the
Company nor the Investor shall have received notice that the SEC has issued or
intends to issue a stop order with respect to the Registration Statement or that
the SEC otherwise has suspended or withdrawn the effectiveness of the
Registration Statement, either temporarily or permanently, or intends or has
threatened to do so (unless the SEC's concerns have been addressed and the
Investor is reasonably satisfied that the SEC no longer is considering or
intends to take such action), and (ii) no other suspension of the use or
withdrawal of the effectiveness of the Registration Statement or related
prospectus shall exist. The Registration Statement must have been declared
effective by the SEC prior to the first Advance Date.

                                       20

<PAGE>

                  (b) Authority. The Company shall have obtained all permits and
qualifications required by any applicable state in accordance with the
Registration Rights Agreement for the offer and sale of the Debentures and the
shares of Common Stock issuable upon the conversion thereof, or shall have the
availability of exemptions therefrom. The sale and issuance of the Debentures
and the shares of Common Stock issuable upon the conversion thereof shall be
legally permitted by all laws and regulations to which the Company is subject.

                  (c) Accuracy of the Company's Representations and Warranties.
The representations and warranties of the Company shall be true and correct in
all material respects as of each Advance Notice Date as though made at each such
time (except for representations and warranties specifically made as of a
particular date) with respect to all periods, and as to all events and
circumstances occurring or existing to and including each Advance Notice Date,
except for any conditions which have temporarily caused any representations or
warranties herein to be incorrect and which have been corrected with no
continuing impairment to the Company or the Investor.

                  (d) Performance by the Company. The Company shall have
performed, satisfied and complied in all material respects with all covenants,
agreements and conditions required by this Agreement, the Debenture and the
Registration Rights Agreement to be performed, satisfied or complied with by the
Company at or prior to each Condition Satisfaction Date.

                  (e) No Injunction. No statute, rule, regulation, executive
order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent
jurisdiction that prohibits or directly and adversely affects any of the
transactions contemplated by this Agreement, and no proceeding shall have been
commenced that may have the effect of prohibiting or adversely affecting any of
the transactions contemplated by this Agreement.

                  (f) Adverse Changes. Since the date of filing of the Company's
most recent SEC Document, no event that had or is reasonably likely to have a
Material Adverse Effect has occurred, other than possible de-listing of the
Common Stock from the Nasdaq Market. The delisting of the Company from such
trading on the Nasdaq market shall not be deemed a Material Adverse Effect if
the Company maintains a listing on any another market.

                  (g) No Suspension of Trading In or Delisting of Common Stock.
The trading of the Common Stock is not suspended by the SEC or the Principal
Market (if the Common Stock is traded on a Principal Market). The issuance of
shares of Common Stock with respect to the applicable Closing, if any, shall not
violate the shareholder approval requirements of the Principal Market (if the
Common Stock is traded on a Principal market).

                  (h) Maximum Advance Amount. The amount of the advance
requested by the Company does not exceed the Maximum Advance Amount.

                  (i) No Knowledge. The Company has no knowledge of any event
more likely than not to have the effect of causing such Registration Statement
to be suspended or otherwise ineffective (which event is more likely than not to
occur within the fifteen (15) Trading Days following the Trading Day on which
such Notice is deemed delivered).

                                       21

<PAGE>

                  (j) Escrow Agreement. The parties hereto shall have entered
into the Escrow Agreement in the form annexed hereto.

                  (k) Other. On each Condition Satisfaction Date, the Investor
shall have received and been reasonably satisfied with such other certificates
and documents as shall have been reasonably requested by the Investor in order
for the Investor to confirm the Company's satisfaction of the conditions set
forth in this Section 7.2, including, without limitation, a certificate in
substantially the form and substance of Exhibit "B" hereto, executed in either
case by an executive officer of the Company and to the effect that all the
conditions to such Closing shall have been satisfied as at the date of each such
certificate.

                                  ARTICLE VIII
         Due Diligence Review; Non-Disclosure of Non-Public Information

         Section 8.1 Due Diligence Review. Prior to the filing of the
Registration Statement the Company shall make available for inspection and
review by the Investor, advisors to and representatives of the Investor, any
underwriter participating in any disposition of the Registrable Securities on
behalf of the Investor pursuant to the Registration Statement, any such
registration statement or amendment or supplement thereto or any blue sky, NASD
or other filing, all financial and other records, all SEC Documents and other
filings with the SEC, and all other corporate documents and properties of the
Company as may be reasonably necessary for the purpose of such review, and cause
the Company's officers, directors and employees to supply all such information
reasonably requested by the Investor or any such representative, advisor or
underwriter in connection with such Registration Statement (including, without
limitation, in response to all questions and other inquiries reasonably made or
submitted by any of them), prior to and from time to time after the filing and
effectiveness of the Registration Statement for the sole purpose of enabling the
Investor and such representatives, advisors and underwriters and their
respective accountants and attorneys to conduct initial and ongoing due
diligence with respect to the Company and the accuracy of the Registration
Statement.

         Section 8.2 Non-Disclosure of Non-Public Information.

                  (a) The Company shall not disclose non-public information to
the Investor, advisors to or representatives of the Investor unless prior to
disclosure of such information the Company identifies such information as being
non-public information and provides the Investor, such advisors and
representatives with the opportunity to accept or refuse to accept such
non-public information for review. The Company may, as a condition to disclosing
any non-public information hereunder, require the Investors advisors and
representatives to enter into a confidentiality agreement in form reasonably
satisfactory to the Company and the Investor.

                                       22

<PAGE>

                  (b) Nothing herein shall require the Company to disclose
non-public information to the Investor or its advisors or representatives, and
the Company represents that it does not disseminate non-public information to
any investors who purchase stock in the Company in a public offering, to money
managers or to securities analysts, provided, however, that notwithstanding
anything herein to the contrary, the Company will, as hereinabove provided,
immediately notify the advisors and representatives of the Investor and, if any,
underwriters, of any event or the existence of any circumstance (without any
obligation to disclose the specific event or circumstance) of which it becomes
aware, constituting non-public information (whether or not requested of the
Company specifically or generally during the course of due diligence by such
persons or entities), which, if not disclosed in the prospectus included in the
Registration Statement would cause such prospectus to include a material
misstatement or to omit a material fact required to be stated therein in order
to make the statements, therein, in light of the circumstances in which they
were made, not misleading. Nothing contained in this Section 8.2 shall be
construed to mean that such persons or entities other than the Investor (without
the written consent of the Investor prior to disclosure of such information) may
not obtain non-public information in the course of conducting due diligence in
accordance with the terms of this Agreement and nothing herein shall prevent any
such persons or entities from notifying the Company of their opinion that based
on such due diligence by such persons or entities, that the Registration
Statement contains an untrue statement of material fact or omits a material fact
required to be stated in the Registration Statement or necessary to make the
statements contained therein, in light of the circumstances in which they were
made, not misleading.

                                   ARTICLE IX
                                     Legends

         Section 9.1 Legends. The Debentures will bear, and the Common Stock
will also bear a similar a legend, substantially in the form below (the
"Legend"):

                  THESE SECURITIES AND THE SHARES ISSUABLE UPON CONVERSION
                  HEREOF, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
                  1933, AS AMENDED (THE "SECURITIES ACT"), OR THE SECURITIES
                  LAWS OF ANY STATE AND MAY NOT BE SOLD OR OFFERED FOR SALE IN
                  THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE
                  SECURITIES OR AN OPINION OF COUNSEL OR OTHER EVIDENCE
                  ACCEPTABLE TO THE CORPORATION THAT SUCH REGISTRATION IS NOT
                  REQUIRED.

                                    ARTICLE X

                           Choice of Law/Jurisdiction

         Section 10.1 Choice of Law: Venue: Jurisdiction. This Agreement will be
construed and enforced in accordance with and governed by the laws of the State
of New York, except for matters arising under the Act, without reference to
principles of conflicts of law. Each of the parties consents to the jurisdiction
of the U.S. District Court sitting in the Southern District of the State of New
York or the state courts of the State of New York sitting in Manhattan in
connection with any dispute arising under this Agreement and hereby waives, to
the maximum extent permitted by law,

                                       23

<PAGE>

any objection, including any objection based on forum non conveniens to the
bringing of any such proceeding in such jurisdictions. Each party hereby agrees
that if another party to this Agreement obtains a judgment against it in such a
proceeding, the party which obtained such judgment may enforce same by summary
judgment in the courts of any country having jurisdiction over the party against
whom such judgment was obtained, and each party hereby waives any defenses
available to it under local law and agrees to the enforcement of such a
judgment. Each party to this Agreement irrevocably consents to the service of
process in any such proceeding by the mailing of copies thereof by registered or
certified mail, postage prepaid, to such party at its address set forth herein.
Nothing herein shall affect the right of any party to serve process in any other
manner permitted by law.

                                   ARTICLE XI
                             Assignment; Termination

         Section 11.1 Assignment. Neither this Agreement nor any rights of the
Investor or the Company hereunder may be assigned by either party to any other
person. Notwithstanding the foregoing, (a) the provisions of this Agreement
shall insure to the benefit of, and be enforceable by, any permitted transferee
of any of the Debentures purchased or acquired by the Investor hereunder with
respect to the Common Stock held by such person, and (b) upon the prior written
consent of the Company, which consent shall not unreasonably be withheld, the
Investor's interest in this Agreement may be assigned at any time, in whole or
in part, to any other person or entity (including any affiliate of the Investor)
who agrees to make the representations and warranties contained in Article III
and who agrees to be bound by the covenants of Article V.

         Section 11.2 Termination. The obligations of the Investor to make
Advances under Article II hereof shall terminate on September 1, 2003.

                                   ARTICLE XII
                                     Notices

         Section 12.1 Notices. All notices, demands, requests, consents,
approvals and other communications required or permitted hereunder shall be in
writing and, unless otherwise specified herein, shall be (i) personally served,
(ii) deposited in the mail, registered or certified, return receipt requested,
postage prepaid, (iii) delivered by reputable air courier service with charges
prepaid, or (iv) transmitted by hand delivery, telegram, or facsimile, addressed
as set forth below or to such other address as such party shall have specified
most recently by written notice.

         Any notice or other communication requested or permitted to be given
hereunder shall be deemed effective (a) upon hand delivery or delivery by
facsimile, with accurate confirmation generated by the transmitting facsimile
machine, at the address or number designed below (if delivered on a business day
during normal business hours where such notice is to be received), or the first
business day following such delivery (if delivered other than on a business day
during normal business hours where such notice is to be received) or (b) on upon
actual receipt of any mailing or delivery, whichever shall first occur. The
addresses for such communications shall be:

                                       24

<PAGE>

If to the Company:

                       TCPI, Inc.
                       3341 S.W. 15th Street
                       Pompano Beach, FL  33069
                       Attention: Walter V. Usinowicz,
                       Chief Financial Officer
                       Telephone: (954) 979-0400
                       Facsimile:  (954) 979-6125

With a copy to:

                       TCPI, Inc.

                       3341 S.W. 15th Street
                       Pompano Beach, FL  33069
                       Attention: General Counsel
                       Telephone:(954) 979-0400
                       Facsimile:   (954) 979-6125

               and

                      Teddy D. Klinghoffer, Esq.
                      Akerman, Senterfitt & Eidson, P.A.
                      Suntrust International Center, 26th Floor
                      One S.E. 3rd Avenue
                      Miami, FL 33131-1714
                      Telephone: (305) 374-5600
                      Facsimile:  (305) 374-5095

         If to the Investor, at the address listed on Schedule A.

         Either party hereto may from time to time change its address or
facsimile number for notices under this Section 12.1 by giving at least ten (10)
days prior written notice of such changed address or facsimile number to the
other party hereto.

                                       25

<PAGE>

                                  ARTICLE XIII
                                  Miscellaneous

         Section 13.1 Counterparts/Facsimile/Amendments. This Agreement may be
executed in multiple counterparts, each of which may be executed by less than
all of the parties and shall be deemed to be an original instrument which shall
be enforceable against the parties actually executing such counterparts and all
of which together shall constitute one and the same instrument. Except as
otherwise stated herein, in lieu of the original documents, a facsimile
transmission or copy of the original documents shall be as effective and
enforceable as the original This Agreement may be amended only by a writing
executed by all parties.

         Section 13.2 Entire Agreement. This Agreement, the Exhibits or
Attachments hereto, which include but are not limited to the Debenture, the
Escrow Agreement, and the Registration Rights Agreement set forth the entire
agreement and understanding of the parties relating to the subject matter hereof
and supersedes all prior and contemporaneous agreements, negotiations and
understanding between the parties, both oral and writing relating to the line of
credit.

         Section 13.3 Reporting Entity for the Common Stock. The reporting
entity relied upon for the determination of the trading price or trading volume
of the Common Stock on any given Trading Day for the purposes of this Agreement
shall be Bloomberg, L.P. or any successor thereto. The written mutual consent of
the Investor and the Company shall be required to employ any other reporting
entity.

         Section 13.4 Fees and Expenses.

         (a) Legal Fees. Each of the parties shall pay its own fees and expenses
(including the fees of any attorneys, accountants, appraisers or others engaged
by such party) in connection with this Agreement and the transactions
contemplated hereby, except that the Company will pay the sum of Twelve Thousand
Five Hundred dollars ($12,500) Dollars, to Butler Gonzalez, L.L.P. for legal,
administrative, and escrow fees, which are hereby acknowledged as being paid..
Subsequently on each Advance Date, the Company will pay Butler Gonzalez, LLP,
the sum of Five Hundred ($ 500) Dollars for escrow fees.

                  (b) Placement Agent Fees. Upon the execution of the Agreement
the Company will issue 350,000 restricted shares of the Company's Common Stock
to the May Davis Group (the "Placement Agent"). In addition the Placement will
receive 50,000 restricted shares of the Company's Common Stock for every One
Hundred Thousand dollars ($100,000) raised in excess of an initial Seven Hundred
Thousand dollars ($700,000) raised. The total amount of the Company's Common
Stock issued shall not exceed seven hundred and fifty thousand (750,000)
restricted shares and the total dollar value of the shares paid shall not exceed
five percent (5%) of the dollar amount of the Credit Line. In the event that
Mark Angelo, Joseph Donahue, Hunter Singer, and Robert Farrell (the
"recipients") terminate their employment with the May Davis Group, Inc., May
Davis Group, Inc., recognizes and directs the Company to issue the subject
shares directly to the Recipients Mark Angelo, Joseph Donahue, Hunter Singer,
and Robert Farrell in amounts determined jointly and such direction shall be
forwarded to the Company in writing. Such shares issued shall have registration
rights as outlined in the Registration Rights Agreementexecuted simultaneously
herewith.

                                       26

<PAGE>

         Section 13.5 Brokerage. Each of the parties hereto represents that it
has had no dealings in connection with this transaction with any finder or
broker who will demand payment of any fee or commission from the other party,
other than the Placement Agent. The Company on the one hand, and the Investor,
on the other hand, agree to indemnify the other against and hold the other
harmless from any and all liabilities to any person claiming brokerage
commissions or finders fees on account of services purported to have been
rendered on behalf of the indemnifying party in connection with this Agreement
or the transactions contemplated hereby.

         Section 13.6 Confidentiality. If for any reason the transactions
contemplated by this Agreement are not consummated, each of the parties hereto
shall keep confidential any information obtained from any other party (except
information publicly available or in such party"s domain prior to the date
hereof, and except as required by court order) and shall promptly return to the
other parties all schedules, documents, instruments, work papers or other
written information without retaining copies thereof, previously furnished by it
as a result of this Agreement or in connection herein.

                                       27

<PAGE>

                                   SIGNATURE

         IN WITNESS WHEREOF, the parties hereto have caused this Line of Credit
Agreement to be executed by the undersigned, thereunto duly authorized, as of
the date first set forth above.

ATTEST

                                     TCPI, INC.

/s/Jay E. Eckhaus
-----------------
Secretary                      BY: /s/ Walter V. Usinowicz, Jr
                                   -------------------------------
                               Name:  Walter V. Usinowicz, Jr.
                               Title: Vice President and Chief Financial Officer

                               INVESTOR
                               GMF HOLDINGS

                               BY: /s/ Diego Davis
                                   -------------------------------
                               Name: Diego Davis

                                       28

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}]]